日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Comment on Karaulic et al. Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma Treatment. Cancers 2025, 17, 3659

对 Karaulic 等人发表于《癌症》(Cancers)2025 年第 17 卷第 3659 页的文章“探索新型应用:重新定位临床批准的髓母细胞瘤治疗疗法”进行评论。

Roesler, Rafael; Jaeger, Mariane da Cunha; de Farias, Caroline Brunetto; Thomaz, Amanda

Possible mechanisms and biomarkers of resistance to vismodegib in SHH medulloblastoma

SHH型髓母细胞瘤对维莫德吉耐药的可能机制和生物标志物

Roesler, Rafael; de Farias, Caroline Brunetto; Brunetto, André T; Gregianin, Lauro; Jaeger, Mariane; Nör, Carolina; Thomaz, Amanda

Antitumor Activities and Cellular Changes Induced by TrkB Inhibition in Medulloblastoma.

TrkB抑制在髓母细胞瘤中诱导的抗肿瘤活性和细胞变化

Thomaz Amanda, Pinheiro Kelly de Vargas, Souza Bárbara Kunzler, Gregianin Lauro, Brunetto Algemir L, Brunetto André T, de Farias Caroline Brunetto, Jaeger Mariane da Cunha, Ramaswamy Vijay, Nör Carolina, Taylor Michael D, Roesler Rafael